Search

Your search keyword '"Lange, Lars"' showing total 97 results

Search Constraints

Start Over You searched for: Author "Lange, Lars" Remove constraint Author: "Lange, Lars" Database Unpaywall Remove constraint Database: Unpaywall
97 results on '"Lange, Lars"'

Search Results

6. Food-Induced Anaphylaxis: Data From the European Anaphylaxis Registry

7. Cow's milk and hen's egg anaphylaxis: A comprehensive data analysis from the European Anaphylaxis Registry

8. Efficacy and safety of peanut epicutaneous immunotherapy in patients with atopic comorbidities

9. Diagnosis and treatment of Hymenoptera venom allergy

10. Guideline for allergological diagnosis of drug hypersensitivity reactions

17. Organ‐specific symptom patterns during oral food challenge in children with peanut and tree nut allergy

18. Different Patterns of Foods Triggering FPIES in Germany

19. Epidemiologie, Krankheitslast und gesundheitsökonomische Aspekte

24. White Paper Erdnussallergie - Teil 1: Epidemiologie, Burden of Disease, gesundheitsökonomische Aspekte

28. Kurzfassung der Leitlinie "Akuttherapie und Management der Anaphylaxie - Update 2021" für Patienten und Angehörige

29. White paper on peanut allergy – part 1: Epidemiology, burden of disease, health economic aspects

30. Messages for patients and relatives from the 2021 update of the guideline on acute therapy and management of anaphylaxis

36. Leitlinie zu Akuttherapie und Management der Anaphylaxie - Update 2021

37. Management des Anaphylaxie-Risikos bei Covid-19-Impfung

38. Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update

39. Identification and Purification of Novel Low-Molecular-Weight Lupine Allergens as Components for Personalized Diagnostics

40. Update of the S2k guideline on the management of IgE-mediated food allergies

41. Anaphylaxie-Risiko bei der COVID-19-Impfung: Empfehlungen für das praktische Management

45. Risk Factors and Characteristics of Biphasic Anaphylaxis

47. Management von Anaphylaxie-gefährdeten Patienten während der Covid-19-Pandemie

48. Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results

50. Is the concept of “peanut-free schools” useful in the routine management of peanut-allergic children at risk of anaphylaxis?

Catalog

Books, media, physical & digital resources